Everyone here blames the drug. Half the time it is the appointment schedule, not the molecule.

The cheapest option costs more once you price in the failure rate. Four months in on Georgia and it lines up.

This board overrates bloodwork. A number moving is not the outcome you wanted.

Be careful reading one parcel as a rule. Two successes build a false model.